Bank of New York Mellon’s NanoViricides NNVC Stock Holding History
Bought
Maintained
Sold
Other funds holding NNVC
WBG
PTB
PAM
SCA
IWM
BC
Bank of New York Mellon's NNVC Position: Q2 2019 in Review
Bank of New York Mellon sold out of NanoViricides (NNVC) in Q2 2019, closing a stake of 1,909 shares — an estimated $10K sold.
Bank of New York Mellon first reported a position in NNVC in Q4 2013 and held it in 22 quarters. The position peaked at $702K in Q2 2014. 36 funds tracked by Wall St. Rank hold NNVC as of Q2 2019.
- Bank of New York Mellon reported no remaining NanoViricides position as of Q2 2019 after selling out during the quarter.
- Bank of New York Mellon sold 1,909 NanoViricides shares in Q2 2019, an estimated $10K.
- Bank of New York Mellon first reported a position in NanoViricides in Q4 2013 and held it in 22 quarters.
- Bank of New York Mellon's NanoViricides position peaked at $702K in Q2 2014.
- 36 funds tracked by Wall St. Rank held NanoViricides as of Q2 2019.
Based on Bank of New York Mellon's 13F filing for Q2 2019, filed 12 Aug 2019.